Improving simulations of enzymatic reactions using advanced computational methods
Multiscale ab initio QM/MM and Machine Learning Methods for Accelerated Free Energy Simulations
This study is working on a new way to speed up computer simulations that help us understand how enzymes work, which could lead to better drugs and treatments for diseases related to enzymes, ultimately benefiting patients like you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Q-Chem, INC. NIH-funded |
| Lab location | 1 site (Pleasanton, United States) |
| Project ID | NIH-10808946 on NIH RePORTER |
What this research studies
This research focuses on enhancing the efficiency of computational simulations that model enzymatic reactions, which are crucial in various biological and chemical processes. By employing a novel multiple time step simulation method, the project aims to significantly reduce the time required to obtain accurate free energy profiles of these reactions. The approach combines less accurate, faster models with more precise, slower quantum chemistry methods to optimize the simulation process. Patients may benefit indirectly through advancements in drug development and understanding of enzyme-related diseases.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions related to enzyme deficiencies or those requiring targeted drug therapies.
Not a fit: Patients with conditions unrelated to enzymatic processes or those not requiring advanced computational modeling for treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate drug discovery processes, ultimately improving treatment options for patients.
How similar studies have performed: Other research in computational chemistry has shown promise in improving simulation methods, indicating that this approach may yield significant advancements.
Where this research is happening
Pleasanton, United States
- Q-Chem, INC. — Pleasanton, United States (Active)
Researchers
- Principal investigator: Feng, Xintian — Q-Chem, INC.
- Study coordinator: Feng, Xintian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.